Kids_First_Biospecimen_ID_DNA	Kids_First_Biospecimen_ID_RNA	Kids_First_Participant_ID	gene_symbol	cancer_group	pathology_free_text_diagnosis	copy_number	MYCN_TPM	status	Match_ID
BS_4NPEMNAD	BS_DY88N5ZT	PT_DFCZAG9T	MYCN	Neuroblastoma	Metastatic secondary tumors;Neuroblastoma	100	83.29	amplification	PT_DFCZAG9T_7316-224_PBTA
BS_5J5VH3X0	BS_2SHWPB5P	PT_FZHGKJ0H	NA	Ganglioneuroblastoma	ganglioneuroblastoma, stage ii favorable histology non n-myc amplified	NA	0.13	NA	PT_FZHGKJ0H_7316-4034_PBTA
BS_CK7CPM73	BS_NFRXNAFE	PT_RXT6KRR6	NA	Ganglioneuroblastoma	ganglioneuroblastoma	NA	4.08	NA	PT_RXT6KRR6_7316-3147_PBTA
BS_F0GNWEJJ	BS_VNWKNRY4	PT_EB0D3BXG	NA	Neuroblastoma	Metastatic secondary tumors;Neuroblastoma	NA	6.73	NA	PT_EB0D3BXG_7316-3311_PBTA
BS_KP0YNTAK	BS_1RT76ANT	PT_5SX0GRW1	MYCN	Neuroblastoma	Metastatic secondary tumors;Neuroblastoma	4	9.38	gain	PT_5SX0GRW1_7316-1927_PBTA
BS_NHMPQ8Q1	BS_JBGZ7HHZ	PT_FZHGKJ0H	NA	Ganglioneuroblastoma	ganglioneuroblastoma, stage ii favorable histology non n-myc amplified	NA	0.02	NA	PT_FZHGKJ0H_7316-4033_PBTA
BS_00PH2T1P	BS_P10Y42BX	PAUIJR	NA	Neuroblastoma	NA	NA	11.77	NA	PAUIJR_01_GMKF
BS_0RBGK29M	BS_KC02E200	PASMIU	MYCN	Neuroblastoma	NA	3	47.21	gain	PASMIU_01_GMKF
BS_0T5A16N2	BS_KHW6ASK4	PAVHWG	NA	Neuroblastoma	NA	NA	15.92	NA	PAVHWG_01_GMKF
BS_0TER803R	BS_ZGKT8MMX	PAVFAP	NA	Neuroblastoma	NA	NA	21.84	NA	PAVFAP_01_GMKF
BS_1G3QX306	BS_FHNTKFVJ	PARZCJ	NA	Neuroblastoma	MYCN non-amp	NA	12.45	NA	PARZCJ_01_GMKF
BS_1G5N5R8S	BS_2Y28PRQC	PARYEH	NA	Neuroblastoma	NA	NA	23.09	NA	PARYEH_01_GMKF
BS_20HSXMYQ	BS_02X4QTNE	PAUIRD	NA	Neuroblastoma	NA	NA	25.8	NA	PAUIRD_01_GMKF
BS_255803B6	BS_3D1XTG0K	PATSTU	NA	Ganglioneuroblastoma, nodular	NA	NA	3.49	NA	PATSTU_01_GMKF
BS_25EXB29C	BS_8V59CEJJ	PATWPC	NA	Neuroblastoma	NA	NA	11.18	NA	PATWPC_01_GMKF
BS_29DZNQYC	BS_3N0ZS3G3	PARXPD	NA	Neuroblastoma	NA	NA	20.55	NA	PARXPD_01_GMKF
BS_29MQMSCM	BS_YZJ5YQ12	PARYAG	NA	Neuroblastoma	NA	NA	1.72	NA	PARYAG_01_GMKF
BS_2ABKFT99	BS_QCDCAX7G	PAUPNR	NA	Neuroblastoma	NA	NA	19.78	NA	PAUPNR_01_GMKF
BS_2FPVHEQS	BS_GR7694W1	PAUUHY	MYCN	Neuroblastoma	NA	145	404.76	amplification	PAUUHY_01_GMKF
BS_2N95EW0G	BS_9TKGBJH7	PASXIE	NA	Neuroblastoma	MYCN amp	NA	485.27	NA	PASXIE_01_GMKF
BS_2NPW3A08	BS_PRF6XPXV	PAVBLT	NA	Neuroblastoma	NA	NA	13.13	NA	PAVBLT_01_GMKF
BS_2R0QBATZ	BS_94JMQ7MX	PAUKLK	NA	Neuroblastoma	NA	NA	250.84	NA	PAUKLK_01_GMKF
BS_2SFR8Z1P	BS_8T0AKNMJ	PASVXS	NA	Neuroblastoma	NA	NA	8.73	NA	PASVXS_01_GMKF
BS_2X9EVKZ0	BS_6N7RPHX9	PASFKX	NA	Neuroblastoma	NA	NA	357.42	NA	PASFKX_01_GMKF
BS_30NT6PNA	BS_6GSJCDCN	PASIIB	NA	Neuroblastoma	NA	NA	12.03	NA	PASIIB_01_GMKF
BS_3564XTTK	BS_3CSY3JTN	PASNUI	MYCN	Neuroblastoma	NA	647	375.71	amplification	PASNUI_01_GMKF
BS_38SSRZJ1	BS_Y2DSNJ1E	PATLBP	NA	Neuroblastoma	NA	NA	13.26	NA	PATLBP_01_GMKF
BS_3AKS23A0	BS_F2F7BXT5	PATLFX	MYCN	Neuroblastoma	NA	3	24.78	gain	PATLFX_01_GMKF
BS_3KPKZVGX	BS_ZKQXXTG9	PAVIZV	NA	Ganglioneuroblastoma, nodular	NA	NA	9.42	NA	PAVIZV_01_GMKF
BS_4GHFYCWZ	BS_QM9CBE54	PAVIAZ	NA	Ganglioneuroblastoma, nodular	NA	NA	1.26	NA	PAVIAZ_01_GMKF
BS_4J8JK335	BS_H4TFY19Z	PAUJEJ	MYCN	Neuroblastoma	NA	5	96.4	amplification	PAUJEJ_01_GMKF
BS_4RX1AAVV	BS_S0B4WASX	PARTRP	NA	Neuroblastoma	NA	NA	14.28	NA	PARTRP_01_GMKF
BS_4VKRBRJC	BS_F9ZXCH60	PATLSY	NA	Ganglioneuroblastoma, nodular	NA	NA	3.17	NA	PATLSY_01_GMKF
BS_588QYDB1	BS_0YPDAAE8	PATWDV	NA	Neuroblastoma	NA	NA	21.05	NA	PATWDV_01_GMKF
BS_5ACNB1BG	BS_CN3256VE	PAULDT	NA	Neuroblastoma	NA	NA	24.55	NA	PAULDT_01_GMKF
BS_5BB8J64W	BS_T7MWWC0A	PAUPWN	MYCN	Neuroblastoma	NA	3	26.39	gain	PAUPWN_01_GMKF
BS_5BFNH9S6	BS_WHX83JW2	PASFWL	NA	Neuroblastoma	NA	NA	32.59	NA	PASFWL_01_GMKF
BS_5CR48ZM7	BS_TGDZ491N	PAUUWG	NA	Ganglioneuroblastoma, intermixed	NA	NA	0.77	NA	PAUUWG_01_GMKF
BS_5DXK26YF	BS_X3F8NMS4	PAUJTY	NA	Neuroblastoma	NA	NA	13.11	NA	PAUJTY_01_GMKF
BS_5QFRPR61	BS_FC37XAZK	PAUPMU	NA	Ganglioneuroblastoma, intermixed	NA	NA	2.69	NA	PAUPMU_01_GMKF
BS_64P50TAP	BS_CZMY8CVE	PATFIK	MYCN	Neuroblastoma	NA	3	42.78	gain	PATFIK_01_GMKF
BS_69KVWAWK	BS_H5RWQDCJ	PASMUB	NA	Neuroblastoma	NA	NA	9.72	NA	PASMUB_01_GMKF
BS_6AENZKKA	BS_Z36F6GKX	PATVKN	NA	Neuroblastoma	NA	NA	10.38	NA	PATVKN_01_GMKF
BS_6FA0NNF1	BS_S0SM38BZ	PATNXK	NA	Neuroblastoma	NA	NA	21.45	NA	PATNXK_01_GMKF
BS_6KH6CXMH	BS_HW9CGZ29	PASLIH	NA	Neuroblastoma	NA	NA	17.83	NA	PASLIH_01_GMKF
BS_6S50RDHT	BS_A9FNKG9K	PATVKI	NA	Neuroblastoma	NA	NA	22.47	NA	PATVKI_01_GMKF
BS_76SQJSHP	BS_BW9QBKEQ	PATXTF	MYCN	Neuroblastoma	NA	5	33.58	gain	PATXTF_01_GMKF
BS_7BJQNVK8	BS_EMBK3HHP	PAVINE	MYCN	Neuroblastoma	NA	3	17.84	gain	PAVINE_01_GMKF
BS_7HRQNWJY	BS_STTGK8V4	PATWPL	NA	Neuroblastoma	NA	NA	31.71	NA	PATWPL_01_GMKF
BS_7MXT22QP	BS_9R8GFR36	PASAGA	NA	Neuroblastoma	NA	NA	8.82	NA	PASAGA_01_GMKF
BS_7W42FH5A	BS_M462FWS9	PATBGF	NA	Neuroblastoma	NA	NA	5.89	NA	PATBGF_01_GMKF
BS_808H2FQN	BS_ERHKS2Y7	PARUZA	NA	Neuroblastoma	NA	NA	0.44	NA	PARUZA_01_GMKF
BS_87J6X9KJ	BS_135GYQQD	PAVNLK	NA	Neuroblastoma	NA	NA	23.32	NA	PAVNLK_01_GMKF
BS_8MJNDM75	BS_MBNSCVMH	PAUXGR	NA	Neuroblastoma	NA	NA	6.25	NA	PAUXGR_01_GMKF
BS_8S0EDFTP	BS_K9VNW7JD	PASSWW	NA	Neuroblastoma	MYCN non-amp	NA	8.75	NA	PASSWW_01_GMKF
BS_8XDZQKSD	BS_MPE34NYZ	PASWYR	MYCN	Neuroblastoma	MYCN amp	3	334.91	gain	PASWYR_01_GMKF
BS_92YFTG9R	BS_JY850J9G	PARYRJ	NA	Neuroblastoma	NA	NA	23.72	NA	PARYRJ_01_GMKF
BS_95PV1RRY	BS_SZ3EJPGV	PAVKRF	NA	Neuroblastoma	NA	NA	10.35	NA	PAVKRF_01_GMKF
BS_9BZBCZHK	BS_VNKT3ZZS	PAUNTY	NA	Neuroblastoma	NA	NA	274.07	NA	PAUNTY_01_GMKF
BS_9CPZ5R1T	BS_RW0JJ9BQ	PASUMK	NA	Ganglioneuroma, maturing subtype OR Ganglioneuroblastoma, well differentiated	NA	NA	0.62	NA	PASUMK_01_GMKF
BS_9ND96NYZ	BS_MDEQHB6J	PASUEZ	NA	Neuroblastoma	NA	NA	31.37	NA	PASUEZ_01_GMKF
BS_9PEJSEZG	BS_AYDD070S	PATPFG	NA	Neuroblastoma	NA	NA	20.29	NA	PATPFG_01_GMKF
BS_9PRG9CJC	BS_MGHRCZEV	PASUVU	NA	Neuroblastoma	NA	NA	23.45	NA	PASUVU_01_GMKF
BS_9ZDR2H7D	BS_XZQE9FBM	PASXSJ	MYCN	Neuroblastoma	NA	106	245.8	amplification	PASXSJ_01_GMKF
BS_A3K94FCY	BS_DHWN3X5S	PATYWG	NA	Neuroblastoma	NA	NA	5.05	NA	PATYWG_01_GMKF
BS_A527Y2QF	BS_S4WH99C9	PATZRF	MYCN	Neuroblastoma	NA	18	213.48	amplification	PATZRF_01_GMKF
BS_A5AQFAFA	BS_QJ3XB7XZ	PATLKI	MYCN	Ganglioneuroblastoma, nodular	NA	3	27.01	gain	PATLKI_01_GMKF
BS_ACCE0MEA	BS_94ZKC2SR	PASPGB	MYCN	Neuroblastoma	NA	3	269.8	gain	PASPGB_01_GMKF
BS_ACDQRWMY	BS_MG1N76FY	PATSUL	NA	Neuroblastoma	NA	NA	7.72	NA	PATSUL_01_GMKF
BS_AE718N55	BS_ZWRZRC4V	PASLTC	MYCN	Neuroblastoma	NA	3	44.21	gain	PASLTC_01_GMKF
BS_APY3G22J	BS_A70FPYSH	PASWEE	MYCN	Neuroblastoma	NA	3	30.4	gain	PASWEE_01_GMKF
BS_B2RYV4GG	BS_S32M2YTY	PATTHB	MYCN	Neuroblastoma	NA	3	20.41	gain	PATTHB_01_GMKF
BS_B6E0477K	BS_N13KZYRR	PASDYT	NA	Neuroblastoma	NA	NA	15.52	NA	PASDYT_01_GMKF
BS_BF83XX7P	BS_NJSZSZX5	PATSCT	MYCN	Neuroblastoma	NA	3	15.73	gain	PATSCT_01_GMKF
BS_BJCTR4C8	BS_GB1XPW06	PAUSJB	NA	Neuroblastoma	NA	NA	9.08	NA	PAUSJB_01_GMKF
BS_BPXHZ3Y0	BS_5W25GMQ1	PATMDE	NA	Ganglioneuroblastoma, intermixed	NA	NA	1.89	NA	PATMDE_01_GMKF
BS_BTRGQHM4	BS_HHNQ3N2V	PAULZB	MYCN	Neuroblastoma	NA	3	21.94	gain	PAULZB_01_GMKF
BS_BVAVPKKN	BS_5Y98E084	PAUYFR	NA	Neuroblastoma	NA	NA	10.62	NA	PAUYFR_01_GMKF
BS_C2FYP4KW	BS_H9BW7Y9C	PAUUTW	MYCN	Neuroblastoma	NA	4	23.53	gain	PAUUTW_01_GMKF
BS_C3KT9THS	BS_8EX2H96N	PASTWY	NA	Neuroblastoma	NA	NA	34.87	NA	PASTWY_01_GMKF
BS_C8T56CWR	BS_DBXCETW2	PARWEV	NA	Neuroblastoma	NA	NA	31.47	NA	PARWEV_01_GMKF
BS_C9YD10Y4	BS_EXEE6TDK	PASSMV	NA	Neuroblastoma	NA	NA	7.01	NA	PASSMV_01_GMKF
BS_CD6KRB1K	BS_GWN2F333	PASRRY	MYCN	Neuroblastoma	NA	3	25.93	gain	PASRRY_01_GMKF
BS_CKVK1AYV	BS_CZ7DWCPE	PASKZT	NA	Neuroblastoma	NA	NA	1.69	NA	PASKZT_01_GMKF
BS_CWPHVM94	BS_48YZKWC2	PAUYJS	MYCN	Neuroblastoma	NA	4	31.01	gain	PAUYJS_01_GMKF
BS_D3N3FG7Y	BS_N05R3CT2	PATCFL	NA	Neuroblastoma	MYCN non-amp	NA	2.91	NA	PATCFL_01_GMKF
BS_D7442ACV	BS_3DJBSNGE	PATBMM	NA	Ganglioneuroblastoma, nodular	MYCN non-amp	NA	11.39	NA	PATBMM_01_GMKF
BS_DFJYRYV1	BS_WHBM0N3Y	PASJTA	NA	Neuroblastoma	NA	NA	18.62	NA	PASJTA_01_GMKF
BS_DGV11G69	BS_RZEEJETF	PASZTC	MYCN	Neuroblastoma	NA	3	19.49	gain	PASZTC_01_GMKF
BS_DWYR5CTE	BS_W5X4568N	PASCWD	MYCN	Neuroblastoma	NA	132	290.47	amplification	PASCWD_01_GMKF
BS_DZ998H9P	BS_BBD7XS5N	PATDCJ	NA	Neuroblastoma	NA	NA	12.57	NA	PATDCJ_01_GMKF
BS_E4N511ZX	BS_E359X3QV	PATUBI	NA	Neuroblastoma	NA	NA	25.17	NA	PATUBI_01_GMKF
BS_E9YW2KHS	BS_VR7XMQZ3	PAUNZM	NA	Neuroblastoma	NA	NA	23.72	NA	PAUNZM_01_GMKF
BS_EDGSP4V6	BS_8GD69HHF	PATVHJ	NA	Neuroblastoma	NA	NA	15.36	NA	PATVHJ_01_GMKF
BS_F6MNG2S0	BS_BG0ZDND2	PARZBH	NA	Neuroblastoma	NA	NA	20.57	NA	PARZBH_01_GMKF
BS_F92J3KBA	BS_JWXQFZY9	PATCVK	NA	Ganglioneuroblastoma, intermixed	NA	NA	14.21	NA	PATCVK_01_GMKF
BS_FAEHNS3Q	BS_4JVC08W2	PASUCU	MYCN	Neuroblastoma	NA	3	21.71	gain	PASUCU_01_GMKF
BS_FJP95JXF	BS_ZFJS669M	PAUJRW	MYCN	Neuroblastoma	NA	3	311.07	gain	PAUJRW_01_GMKF
BS_FR9R7VFY	BS_YMWFA93F	PAUCIK	NA	Neuroblastoma	NA	NA	10.94	NA	PAUCIK_01_GMKF
BS_FXG6F3NN	BS_WKC3GR0D	PATSNC	NA	Neuroblastoma	NA	NA	7.71	NA	PATSNC_01_GMKF
BS_G4W213NW	BS_DHXNWXP6	PATTNX	NA	Neuroblastoma	NA	NA	32.88	NA	PATTNX_01_GMKF
BS_GAA781GQ	BS_MH01GQ2B	PATNXJ	NA	Neuroblastoma	NA	NA	25.73	NA	PATNXJ_01_GMKF
BS_GBS4JMAZ	BS_NKGRBE18	PATTPC	NA	Neuroblastoma	NA	NA	334.56	NA	PATTPC_01_GMKF
BS_GFN4FETJ	BS_2480EHNY	PATIIT	NA	Neuroblastoma	NA	NA	38.41	NA	PATIIT_01_GMKF
BS_GNETMRJF	BS_KG9X0NFD	PAVINT	NA	Neuroblastoma	NA	NA	8.07	NA	PAVINT_01_GMKF
BS_GZG7GH62	BS_TT20NP68	PAUNST	MYCN	Neuroblastoma	NA	3	23.2	gain	PAUNST_01_GMKF
BS_H0MVFRCE	BS_NZDEF29S	PAVALS	NA	Neuroblastoma	NA	NA	29.09	NA	PAVALS_01_GMKF
BS_HCWEF4QN	BS_Z3BZ01S1	PATBFN	NA	Neuroblastoma	NA	NA	27.74	NA	PATBFN_01_GMKF
BS_HQC1EKZ8	BS_0JBZPAGN	PAUAEE	NA	Neuroblastoma	NA	NA	29.2	NA	PAUAEE_01_GMKF
BS_HYX0M8VM	BS_REGK1PS6	PASCGM	NA	Neuroblastoma	NA	NA	5.32	NA	PASCGM_01_GMKF
BS_HZKJMB0D	BS_YA56YE71	PATWED	MYCN	Neuroblastoma	NA	29	74.25	amplification	PATWED_01_GMKF
BS_J3707KE2	BS_28ZRHXX8	PASAVJ	NA	Neuroblastoma	NA	NA	20.6	NA	PASAVJ_01_GMKF
BS_J6FPW4H0	BS_FJAQ3KAX	PAVFNX	NA	Neuroblastoma	NA	NA	26	NA	PAVFNX_01_GMKF
BS_JGVTE14P	BS_15ED4VDX	PASBDN	NA	Neuroblastoma	NA	NA	26.45	NA	PASBDN_01_GMKF
BS_JQ0XD1K9	BS_EE5Z0Z4J	PASKFM	NA	Neuroblastoma	NA	NA	48.27	NA	PASKFM_01_GMKF
BS_JTP91S1A	BS_2RFA5NWH	PAUWBU	NA	Neuroblastoma	NA	NA	25.84	NA	PAUWBU_01_GMKF
BS_JV1GTZ1Q	BS_82Q78622	PAVGYW	MYCN	Neuroblastoma	NA	3	30.16	gain	PAVGYW_01_GMKF
BS_JZFMHGNX	BS_ETC8R0TD	PATJDG	NA	Neuroblastoma	NA	NA	1.49	NA	PATJDG_01_GMKF
BS_K2K5YSDS	BS_S5KDWVEA	PARUTJ	NA	Neuroblastoma	NA	NA	0.39	NA	PARUTJ_01_GMKF
BS_K5DHTP34	BS_3GRJH3PS	PATETW	NA	Neuroblastoma	NA	NA	15.41	NA	PATETW_01_GMKF
BS_K62HBS01	BS_WFCVBVDS	PATSRY	NA	Neuroblastoma	NA	NA	22.43	NA	PATSRY_01_GMKF
BS_KE5D12KG	BS_W3ZSVEVP	PASFEU	NA	Ganglioneuroblastoma, intermixed	NA	NA	1.56	NA	PASFEU_01_GMKF
BS_KTHF096D	BS_HEJAPS03	PAUCNL	NA	Neuroblastoma	NA	NA	23.14	NA	PAUCNL_01_GMKF
BS_KXRFQF5N	BS_1BKHK7AY	PASXRJ	NA	Neuroblastoma	MYCN non-amp	NA	12.66	NA	PASXRJ_01_GMKF
BS_M7D3Q30Z	BS_XME1VS17	PAUVPT	NA	Ganglioneuroblastoma, nodular	NA	NA	8.67	NA	PAUVPT_01_GMKF
BS_MCCJ3EMF	BS_Z0MTZA9K	PASFEV	NA	Neuroblastoma	NA	NA	31.74	NA	PASFEV_01_GMKF
BS_MJ2H7ZT3	BS_59ZF7365	PASMGS	NA	Neuroblastoma	NA	NA	26.23	NA	PASMGS_01_GMKF
BS_MMBWD5VD	BS_KF4AR0FG	PAURJG	NA	Neuroblastoma	NA	NA	23.52	NA	PAURJG_01_GMKF
BS_MW0JYGG1	BS_6DXDS5EE	PAVHGP	NA	Neuroblastoma	NA	NA	20.97	NA	PAVHGP_01_GMKF
BS_NB0ESCXK	BS_AND83V3S	PATTCU	NA	Neuroblastoma	NA	NA	18.95	NA	PATTCU_01_GMKF
BS_NK1FJNRG	BS_XHSRBERM	PATNUK	NA	Neuroblastoma	NA	NA	10.18	NA	PATNUK_01_GMKF
BS_NNH2A86D	BS_10MQQC5C	PATUPN	NA	Ganglioneuroblastoma, nodular	NA	NA	12.6	NA	PATUPN_01_GMKF
BS_NQN1P6QY	BS_J9EH31NM	PAUGVZ	NA	Neuroblastoma	NA	NA	13.7	NA	PAUGVZ_01_GMKF
BS_NV00B2Y5	BS_63ACHY8K	PAUKYI	NA	Ganglioneuroblastoma, nodular	NA	NA	1.44	NA	PAUKYI_01_GMKF
BS_NV9ZB445	BS_VV8GRGZ6	PAUHXD	NA	Neuroblastoma	NA	NA	18.85	NA	PAUHXD_01_GMKF
BS_NVJJJ7MT	BS_WKPG4MH1	PASNHY	MYCN	Neuroblastoma	NA	3	40.72	gain	PASNHY_01_GMKF
BS_NX91DYXQ	BS_MEN59ZX5	PAVCLX	NA	Neuroblastoma	NA	NA	42.06	NA	PAVCLX_01_GMKF
BS_P0BHM8S1	BS_CCV91DR0	PAUMJN	MYCN	Neuroblastoma	NA	59	57.78	amplification	PAUMJN_01_GMKF
BS_P5VHEN5Q	BS_R232Y3SW	PAVLFB	NA	Neuroblastoma	NA	NA	41.25	NA	PAVLFB_01_GMKF
BS_P6FPBJM8	BS_9JBYGRQW	PASXRG	NA	Ganglioneuroblastoma, nodular	MYCN amp	NA	163.86	NA	PASXRG_01_GMKF
BS_PGBR1H2A	BS_SM1QE9FJ	PAUCRL	NA	Ganglioneuroblastoma, nodular	NA	NA	8.93	NA	PAUCRL_01_GMKF
BS_PKHXM1NB	BS_XJDB3R9K	PATAAV	NA	Neuroblastoma	NA	NA	7.94	NA	PATAAV_01_GMKF
BS_PNF2SHN9	BS_8EG9GQZS	PAVBLZ	NA	Neuroblastoma	NA	NA	24.19	NA	PAVBLZ_01_GMKF
BS_PQFKEKEW	BS_WR5VE59B	PASFCG	NA	Neuroblastoma	NA	NA	23.19	NA	PASFCG_01_GMKF
BS_PS8TB6Z0	BS_HA1N9VCX	PASTZR	NA	Neuroblastoma	NA	NA	17.75	NA	PASTZR_01_GMKF
BS_QCP0VAZ7	BS_6Y5F3QGV	PASREY	NA	Neuroblastoma	MYCN amp	NA	10	NA	PASREY_01_GMKF
BS_QDMDQ3E3	BS_T4KS08ND	PASVYV	NA	Neuroblastoma	NA	NA	30.79	NA	PASVYV_01_GMKF
BS_QDRHQSPZ	BS_6WBAV14H	PASKIS	MYCN	Neuroblastoma	NA	3	313.7	gain	PASKIS_01_GMKF
BS_QKTJ4QY9	BS_A2HY1DZA	PASGGD	NA	Neuroblastoma	NA	NA	12.93	NA	PASGGD_01_GMKF
BS_QWX24M4X	BS_5Y7PNW71	PAVKZC	NA	Ganglioneuroblastoma, nodular	NA	NA	1.32	NA	PAVKZC_01_GMKF
BS_QZAV7XVF	BS_NN42N0XB	PATSUB	NA	Neuroblastoma	NA	NA	21.78	NA	PATSUB_01_GMKF
BS_R0WH31Q0	BS_HEKMP7BH	PATNWM	NA	Neuroblastoma	NA	NA	19.32	NA	PATNWM_01_GMKF
BS_R13WNSAR	BS_GMH5C45K	PASWXG	MYCN	Neuroblastoma	NA	54	345.49	amplification	PASWXG_01_GMKF
BS_R66Z3ENM	BS_KBXSSXWF	PATWIL	NA	Neuroblastoma	NA	NA	18.11	NA	PATWIL_01_GMKF
BS_RA5HNMDP	BS_0SC4QNTM	PASMET	NA	Neuroblastoma	NA	NA	76.25	NA	PASMET_01_GMKF
BS_RFEDCJTP	BS_WKVJJF3F	PAUMFN	NA	Neuroblastoma	NA	NA	30.69	NA	PAUMFN_01_GMKF
BS_RQZZ6T97	BS_S01DMJ5X	PASTRD	NA	Neuroblastoma	NA	NA	2.87	NA	PASTRD_01_GMKF
BS_RR3T675W	BS_323GG6M7	PAVAEE	NA	Neuroblastoma	NA	NA	18.35	NA	PAVAEE_01_GMKF
BS_S4R97RNZ	BS_KYGRX01W	PATNVA	NA	Neuroblastoma	NA	NA	11.36	NA	PATNVA_01_GMKF
BS_S8Q6R8MX	BS_70H191SN	PAVJEG	NA	Neuroblastoma	NA	NA	4.49	NA	PAVJEG_01_GMKF
BS_SMJRCVQB	BS_0D3SCV7P	PATXKN	MYCN	Neuroblastoma	NA	3	8.29	gain	PATXKN_01_GMKF
BS_SPGHWHXY	BS_CD6WEHG9	PASXWF	NA	Neuroblastoma	NA	NA	1.98	NA	PASXWF_01_GMKF
BS_SSHQFYA8	BS_EF8F5GH8	PASBHS	NA	Neuroblastoma	NA	NA	20.81	NA	PASBHS_01_GMKF
BS_STK02B14	BS_NPG879ST	PATUWG	NA	Neuroblastoma	NA	NA	5.22	NA	PATUWG_01_GMKF
BS_SY6CCX4G	BS_19PXZ71B	PASIUJ	NA	Neuroblastoma	NA	NA	146.01	NA	PASIUJ_01_GMKF
BS_SYSZCYYZ	BS_97SKFHM4	PASCDX	MYCN	Neuroblastoma	NA	222	171.07	amplification	PASCDX_01_GMKF
BS_T5BAS1JN	BS_8MYS5HP4	PAUGJI	MYCN	Neuroblastoma	NA	68	241.34	amplification	PAUGJI_01_GMKF
BS_T9KJYH7M	BS_8NQWYZHR	PATPPY	NA	Neuroblastoma	NA	NA	20.95	NA	PATPPY_01_GMKF
BS_T9VPRPVA	BS_3KGHX57D	PASFXC	MYCN	Neuroblastoma	NA	3	19.69	gain	PASFXC_01_GMKF
BS_TBSPYEEW	BS_YBD5FS1Q	PAUPKS	NA	Neuroblastoma	NA	NA	22.5	NA	PAUPKS_01_GMKF
BS_TS07B3TC	BS_5Z1QJPG6	PASRTR	MYCN	Neuroblastoma	NA	3	54.09	gain	PASRTR_01_GMKF
BS_TT4PHFV7	BS_3CTRC269	PASWMY	NA	Neuroblastoma	NA	NA	13.46	NA	PASWMY_01_GMKF
BS_TWN989ZD	BS_YF5NCTGA	PATDKL	NA	Ganglioneuroblastoma, intermixed	NA	NA	3.73	NA	PATDKL_01_GMKF
BS_V4VGG98Y	BS_EZRVK9ZQ	PASXHE	MYCN	Neuroblastoma	MYCN non-amp	3	29.28	gain	PASXHE_01_GMKF
BS_V7B79J5R	BS_9C595Y9M	PASLPG	NA	Neuroblastoma	NA	NA	8.14	NA	PASLPG_01_GMKF
BS_VCXG53E7	BS_78A01TS9	PAUDFR	NA	Neuroblastoma	NA	NA	10.09	NA	PAUDFR_01_GMKF
BS_VE90VKZY	BS_591ZWG14	PAUVML	NA	Neuroblastoma	NA	NA	3.66	NA	PAUVML_01_GMKF
BS_VKK21QBZ	BS_JBKQ59CW	PATGIW	NA	Ganglioneuroblastoma, intermixed	NA	NA	5.62	NA	PATGIW_01_GMKF
BS_W09W6AAS	BS_FE3BY6DT	PATBCM	NA	Ganglioneuroblastoma, nodular	NA	NA	4.51	NA	PATBCM_01_GMKF
BS_W22EEJCZ	BS_DYHEFXJC	PASFIC	NA	Neuroblastoma	MYCN non-amp	NA	12.39	NA	PASFIC_01_GMKF
BS_W41Y820G	BS_QS2NKZW3	PASKRS	NA	Neuroblastoma	NA	NA	10.13	NA	PASKRS_01_GMKF
BS_WBTZK7A2	BS_HBMHZEGZ	PAVJEV	NA	Neuroblastoma	NA	NA	13.27	NA	PAVJEV_01_GMKF
BS_WBZBDN0A	BS_6YYC47K2	PAUEXM	MYCN	Neuroblastoma	NA	4	36.01	gain	PAUEXM_01_GMKF
BS_WCEHT7D0	BS_NR090DDV	PATIRK	NA	Ganglioneuroblastoma, intermixed	NA	NA	5.51	NA	PATIRK_01_GMKF
BS_WFZG82XZ	BS_XFFQR05Z	PATEEE	NA	Neuroblastoma	NA	NA	7.9	NA	PATEEE_01_GMKF
BS_WRZATZQF	BS_JFJYEHFM	PATLFF	MYCN	Neuroblastoma	NA	3	16.22	gain	PATLFF_01_GMKF
BS_X2D8S1HY	BS_8VPBB5C2	PASEWZ	MYCN	Neuroblastoma	NA	3	38.35	gain	PASEWZ_01_GMKF
BS_X3AFTRNM	BS_DERH44Z2	PATSIJ	NA	Ganglioneuroblastoma, nodular	NA	NA	18.1	NA	PATSIJ_01_GMKF
BS_X8H38ZNB	BS_KV05J5BX	PAVHEU	NA	Neuroblastoma	NA	NA	5.53	NA	PAVHEU_01_GMKF
BS_XA3KEKC6	BS_MAJ800Q0	PASDDP	NA	Neuroblastoma	NA	NA	19.03	NA	PASDDP_01_GMKF
BS_XQC9PNZP	BS_GTFHNG3R	PATFTR	NA	Neuroblastoma	NA	NA	25.02	NA	PATFTR_01_GMKF
BS_XQSEQPAZ	BS_EPZ2H50J	PASYYZ	NA	Ganglioneuroblastoma, intermixed	NA	NA	1.12	NA	PASYYZ_01_GMKF
BS_XWKDJ2M6	BS_4A1CKAXN	PATDWR	NA	Neuroblastoma	NA	NA	14.34	NA	PATDWR_01_GMKF
BS_XX68G6KE	BS_HP8EEDS6	PATUAI	NA	Neuroblastoma	NA	NA	8.26	NA	PATUAI_01_GMKF
BS_Y3KBY0FY	BS_B2BWSTJV	PAVDFW	NA	Neuroblastoma	NA	NA	0.42	NA	PAVDFW_01_GMKF
BS_Y4V9JXG4	BS_2XTH5QRD	PASUFD	NA	Neuroblastoma	NA	NA	5.46	NA	PASUFD_01_GMKF
BS_Y9BHAPG3	BS_FRY5NFRY	PASZRF	NA	Neuroblastoma	NA	NA	16.28	NA	PASZRF_01_GMKF
BS_YK9W04XG	BS_9BYP1GZS	PATKGB	NA	Neuroblastoma	NA	NA	38.94	NA	PATKGB_01_GMKF
BS_YPKSF86W	BS_83RF7CY6	PATVRG	NA	Neuroblastoma	NA	NA	9.4	NA	PATVRG_01_GMKF
BS_YTQ6Y7FQ	BS_C84NQED0	PATWTJ	NA	Neuroblastoma	NA	NA	14.56	NA	PATWTJ_01_GMKF
BS_YV3MJ2BD	BS_K59AGJKW	PAULMT	NA	Neuroblastoma	NA	NA	12	NA	PAULMT_01_GMKF
BS_Z2G9EG1X	BS_AFRGW493	PASAHC	NA	Neuroblastoma	NA	NA	17.71	NA	PASAHC_01_GMKF
BS_Z862V8M7	BS_NPVE58AT	PARVPD	NA	Neuroblastoma	NA	NA	11.83	NA	PARVPD_01_GMKF
BS_ZED6T1CT	BS_896YFFGE	PAUTFT	MYCN	Neuroblastoma	NA	30	75.36	amplification	PAUTFT_01_GMKF
BS_ZK0GRMB1	BS_FXDGYFBR	PAUFHY	NA	Ganglioneuroblastoma, nodular	NA	NA	1.32	NA	PAUFHY_01_GMKF
BS_ZPXVVM8K	BS_NC4PWRVP	PAUWHB	NA	Neuroblastoma	NA	NA	10.59	NA	PAUWHB_01_GMKF
BS_ZRG2V7T2	BS_CXGWN1W5	PASZJB	NA	Neuroblastoma	NA	NA	18.74	NA	PASZJB_01_GMKF
TARGET-30-PAIFXV-01A-01D	TARGET-30-PAIFXV-01A-01R	PAIFXV	MYCN	Neuroblastoma	MYCN non-amp	3	3.38	gain	PAIFXV_01_TARGET
TARGET-30-PAIPGU-01A-01W	TARGET-30-PAIPGU-01A-01R	PAIPGU	MYCN	Neuroblastoma	MYCN non-amp	3	20.29	gain	PAIPGU_01_TARGET
TARGET-30-PAITCI-01A-01W	TARGET-30-PAITCI-01A-01R	PAITCI	MYCN	Neuroblastoma	MYCN non-amp	2	20.11	loss	PAITCI_01_TARGET
TARGET-30-PAITEG-01A-01W	TARGET-30-PAITEG-01A-01R	PAITEG	MYCN	Neuroblastoma	MYCN non-amp	2	1.41	neutral	PAITEG_01_TARGET
TARGET-30-PAIVHE-01A-01W	TARGET-30-PAIVHE-01A-01R	PAIVHE	MYCN	Neuroblastoma	MYCN non-amp	2	45.8	loss	PAIVHE_01_TARGET
TARGET-30-PAKYZS-01A-01W	TARGET-30-PAKYZS-01A-01R	PAKYZS	MYCN	Neuroblastoma	MYCN non-amp	2	10.09	neutral	PAKYZS_01_TARGET
TARGET-30-PALBFW-01A-01W	TARGET-30-PALBFW-01A-01R	PALBFW	MYCN	Neuroblastoma	MYCN non-amp	2	25.2	neutral	PALBFW_01_TARGET
TARGET-30-PALCBW-01A-01W	TARGET-30-PALCBW-01A-01R	PALCBW	MYCN	Neuroblastoma	MYCN non-amp	2	3.82	loss	PALCBW_01_TARGET
TARGET-30-PALETP-01A-01W	TARGET-30-PALETP-01A-01R	PALETP	MYCN	Neuroblastoma	MYCN non-amp	2	38.47	neutral	PALETP_01_TARGET
TARGET-30-PALEVG-01A-01W	TARGET-30-PALEVG-01A-01R	PALEVG	MYCN	Neuroblastoma	MYCN amp	44	841.17	amplification	PALEVG_01_TARGET
TARGET-30-PALIIN-01A-01W	TARGET-30-PALIIN-01A-01R	PALIIN	MYCN	Neuroblastoma	MYCN non-amp	2	65.69	loss	PALIIN_01_TARGET
TARGET-30-PALTEG-01A-01W	TARGET-30-PALTEG-01A-01R	PALTEG	MYCN	Neuroblastoma	MYCN non-amp	2	20.09	neutral	PALTEG_01_TARGET
TARGET-30-PALWVJ-01A-01W	TARGET-30-PALWVJ-01A-01R	PALWVJ	MYCN	Neuroblastoma	MYCN non-amp	2	10.08	neutral	PALWVJ_01_TARGET
TARGET-30-PALZZV-01A-01W	TARGET-30-PALZZV-01A-01R	PALZZV	MYCN	Neuroblastoma	MYCN amp	86	888.26	amplification	PALZZV_01_TARGET
TARGET-30-PAMMXF-01A-01W	TARGET-30-PAMMXF-01A-01R	PAMMXF	MYCN	Neuroblastoma	MYCN amp	2	536	neutral	PAMMXF_01_TARGET
TARGET-30-PAMVRA-01A-01W	TARGET-30-PAMVRA-01A-01R	PAMVRA	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	65.33	loss	PAMVRA_01_TARGET
TARGET-30-PAMYCE-01A-01W	TARGET-30-PAMYCE-01A-01R	PAMYCE	MYCN	Neuroblastoma	MYCN non-amp	2	26.63	loss	PAMYCE_01_TARGET
TARGET-30-PAMZGT-01A-01W	TARGET-30-PAMZGT-01A-01R	PAMZGT	MYCN	Neuroblastoma	MYCN amp	23	238.17	amplification	PAMZGT_01_TARGET
TARGET-30-PAMZMG-01A-01W	TARGET-30-PAMZMG-01A-01R	PAMZMG	MYCN	Neuroblastoma	MYCN amp	44	641.29	amplification	PAMZMG_01_TARGET
TARGET-30-PANBMJ-01A-01W	TARGET-30-PANBMJ-01A-01R	PANBMJ	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	3.78	neutral	PANBMJ_01_TARGET
TARGET-30-PANBSP-01A-01W	TARGET-30-PANBSP-01A-01R	PANBSP	MYCN	Neuroblastoma	MYCN non-amp	3	52.35	neutral	PANBSP_01_TARGET
TARGET-30-PANKFE-01A-01W	TARGET-30-PANKFE-01A-01R	PANKFE	MYCN	Neuroblastoma	MYCN non-amp	2	4.74	neutral	PANKFE_01_TARGET
TARGET-30-PANLET-01A-01D	TARGET-30-PANLET-01A-01R	PANLET	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	36.1	loss	PANLET_01_TARGET
TARGET-30-PANRHJ-01A-01W	TARGET-30-PANRHJ-01A-01R	PANRHJ	MYCN	Neuroblastoma	MYCN non-amp	2	25.28	neutral	PANRHJ_01_TARGET
TARGET-30-PANRVJ-01A-01D	TARGET-30-PANRVJ-01A-01R	PANRVJ	MYCN	Neuroblastoma	MYCN non-amp	2	30.22	loss	PANRVJ_01_TARGET
TARGET-30-PANSBN-01A-01D	TARGET-30-PANSBN-01A-01R	PANSBN	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	0.74	neutral	PANSBN_01_TARGET
TARGET-30-PANUIF-01A-01D	TARGET-30-PANUIF-01A-01R	PANUIF	MYCN	Neuroblastoma	MYCN non-amp	3	14.77	gain	PANUIF_01_TARGET
TARGET-30-PANWRR-01A-01D	TARGET-30-PANWRR-01A-01R	PANWRR	MYCN	Neuroblastoma	MYCN non-amp	2	47.51	neutral	PANWRR_01_TARGET
TARGET-30-PANXJL-01A-01D	TARGET-30-PANXJL-01A-01R	PANXJL	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	1.77	loss	PANXJL_01_TARGET
TARGET-30-PANYGR-01A-01W	TARGET-30-PANYGR-01A-01R	PANYGR	MYCN	Neuroblastoma	MYCN non-amp	2	36.9	loss	PANYGR_01_TARGET
TARGET-30-PANZPV-01A-01W	TARGET-30-PANZPV-01A-01R	PANZPV	MYCN	Neuroblastoma	MYCN non-amp	2	12.32	loss	PANZPV_01_TARGET
TARGET-30-PANZVU-01A-01W	TARGET-30-PANZVU-01A-01R	PANZVU	MYCN	Neuroblastoma	MYCN non-amp	2	41.2	loss	PANZVU_01_TARGET
TARGET-30-PAPBGH-01A-01W	TARGET-30-PAPBGH-01A-01R	PAPBGH	MYCN	Neuroblastoma	MYCN non-amp	2	0.51	loss	PAPBGH_01_TARGET
TARGET-30-PAPBJE-01A-01D	TARGET-30-PAPBJE-01A-01R	PAPBJE	MYCN	Neuroblastoma	MYCN amp	216	794.4	amplification	PAPBJE_01_TARGET
TARGET-30-PAPBZI-01A-01W	TARGET-30-PAPBZI-01A-01R	PAPBZI	MYCN	Neuroblastoma	MYCN non-amp	4	24.12	gain	PAPBZI_01_TARGET
TARGET-30-PAPCTS-01A-01D	TARGET-30-PAPCTS-01A-01R	PAPCTS	MYCN	Neuroblastoma	MYCN amp	129	1730.92	amplification	PAPCTS_01_TARGET
TARGET-30-PAPEFE-01A-01W	TARGET-30-PAPEFE-01A-01R	PAPEFE	MYCN	Neuroblastoma	MYCN amp	7	256.18	amplification	PAPEFE_01_TARGET
TARGET-30-PAPHPE-01A-01W	TARGET-30-PAPHPE-01A-01R	PAPHPE	MYCN	Neuroblastoma	MYCN non-amp	3	6.75	neutral	PAPHPE_01_TARGET
TARGET-30-PAPKWN-01A-01W	TARGET-30-PAPKWN-01A-01R	PAPKWN	MYCN	Neuroblastoma	MYCN amp	13	53.77	amplification	PAPKWN_01_TARGET
TARGET-30-PAPKXS-01A-01D	TARGET-30-PAPKXS-01A-01R	PAPKXS	MYCN	Neuroblastoma	MYCN non-amp	3	156.12	gain	PAPKXS_01_TARGET
TARGET-30-PAPLSD-01A-01D	TARGET-30-PAPLSD-01A-01R	PAPLSD	MYCN	Neuroblastoma	MYCN non-amp	3	27.18	gain	PAPLSD_01_TARGET
TARGET-30-PAPTAN-01A-01D	TARGET-30-PAPTAN-01A-01R	PAPTAN	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	17.55	neutral	PAPTAN_01_TARGET
TARGET-30-PAPTCR-01A-01D	TARGET-30-PAPTCR-01A-01R	PAPTCR	MYCN	Neuroblastoma	NA	2	6.25	neutral	PAPTCR_01_TARGET
TARGET-30-PAPTFZ-01A-01D	TARGET-30-PAPTFZ-01A-01R	PAPTFZ	MYCN	Neuroblastoma	MYCN amp	125	963.04	amplification	PAPTFZ_01_TARGET
TARGET-30-PAPTLV-01A-01D	TARGET-30-PAPTLV-01A-01R	PAPTLV	MYCN	Neuroblastoma	MYCN amp	24	287.38	amplification	PAPTLV_01_TARGET
TARGET-30-PAPUWY-01A-01D	TARGET-30-PAPUWY-01A-01R	PAPUWY	MYCN	Neuroblastoma	MYCN non-amp	2	54.03	loss	PAPUWY_01_TARGET
TARGET-30-PAPVFD-01A-01D	TARGET-30-PAPVFD-01A-01R	PAPVFD	MYCN	Neuroblastoma	MYCN non-amp	3	83.89	neutral	PAPVFD_01_TARGET
TARGET-30-PAPVRN-01A-01D	TARGET-30-PAPVRN-01A-01R	PAPVRN	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	7.12	loss	PAPVRN_01_TARGET
TARGET-30-PAPVXS-01A-01D	TARGET-30-PAPVXS-01A-01R	PAPVXS	MYCN	Neuroblastoma	MYCN non-amp	3	41.63	neutral	PAPVXS_01_TARGET
TARGET-30-PAPZYZ-01A-01D	TARGET-30-PAPZYZ-01A-01R	PAPZYZ	MYCN	Neuroblastoma	MYCN amp	131	297.49	amplification	PAPZYZ_01_TARGET
TARGET-30-PARACS-01A-01D	TARGET-30-PARACS-01A-01R	PARACS	MYCN	Neuroblastoma	MYCN non-amp	3	41.99	neutral	PARACS_01_TARGET
TARGET-30-PARAMT-01A-01D	TARGET-30-PARAMT-01A-01R	PARAMT	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	3	84.91	neutral	PARAMT_01_TARGET
TARGET-30-PARBGP-01A-01D	TARGET-30-PARBGP-01A-01R	PARBGP	MYCN	Neuroblastoma	MYCN non-amp	2	64.79	loss	PARBGP_01_TARGET
TARGET-30-PARDCK-01A-01D	TARGET-30-PARDCK-01A-01R	PARDCK	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	9.06	loss	PARDCK_01_TARGET
TARGET-30-PARDIW-01A-01D	TARGET-30-PARDIW-01A-01R	PARDIW	MYCN	Neuroblastoma	MYCN non-amp	2	27.17	loss	PARDIW_01_TARGET
TARGET-30-PARFWB-01A-01D	TARGET-30-PARFWB-01A-01R	PARFWB	MYCN	Neuroblastoma	MYCN non-amp	2	39.63	neutral	PARFWB_01_TARGET
TARGET-30-PARGKK-01A-01D	TARGET-30-PARGKK-01A-01R	PARGKK	MYCN	Neuroblastoma	MYCN non-amp	2	37.51	neutral	PARGKK_01_TARGET
TARGET-30-PARKGJ-01A-01D	TARGET-30-PARKGJ-01A-01R	PARKGJ	MYCN	Neuroblastoma	MYCN non-amp	3	11.58	gain	PARKGJ_01_TARGET
TARGET-30-PARSBI-01A-01D	TARGET-30-PARSBI-01A-01R	PARSBI	MYCN	Neuroblastoma	MYCN non-amp	2	14.69	loss	PARSBI_01_TARGET
TARGET-30-PARVLK-01A-01D	TARGET-30-PARVLK-01A-01R	PARVLK	MYCN	Ganglioneuroblastoma, intermixed	MYCN non-amp	2	13.46	loss	PARVLK_01_TARGET
TARGET-30-PARYNK-01A-01D	TARGET-30-PARYNK-01A-01R	PARYNK	MYCN	Neuroblastoma	MYCN non-amp	2	6.28	neutral	PARYNK_01_TARGET
TARGET-30-PARZIP-01A-01D	TARGET-30-PARZIP-01A-01R	PARZIP	MYCN	Neuroblastoma	MYCN non-amp	3	61.24	loss	PARZIP_01_TARGET
TARGET-30-PASEGA-01A-01D	TARGET-30-PASEGA-01A-01R	PASEGA	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	19.7	neutral	PASEGA_01_TARGET
TARGET-30-PASFGG-01A-01D	TARGET-30-PASFGG-01A-01R	PASFGG	MYCN	Neuroblastoma	MYCN non-amp	2	22.7	neutral	PASFGG_01_TARGET
TARGET-30-PASGAP-01A-01D	TARGET-30-PASGAP-01A-01R	PASGAP	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	6.4	loss	PASGAP_01_TARGET
TARGET-30-PASGUT-01A-01D	TARGET-30-PASGUT-01A-01R	PASGUT	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	25.36	loss	PASGUT_01_TARGET
TARGET-30-PASMJG-01A-01D	TARGET-30-PASMJG-01A-01R	PASMJG	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	1.99	neutral	PASMJG_01_TARGET
TARGET-30-PASMNT-01A-01D	TARGET-30-PASMNT-01A-01R	PASMNT	MYCN	Neuroblastoma	MYCN non-amp	2	53.58	neutral	PASMNT_01_TARGET
TARGET-30-PASNEF-01A-01D	TARGET-30-PASNEF-01A-01R	PASNEF	MYCN	Neuroblastoma	MYCN non-amp	2	38.07	loss	PASNEF_01_TARGET
TARGET-30-PASNZU-01A-01D	TARGET-30-PASNZU-01A-01R	PASNZU	MYCN	Neuroblastoma	MYCN amp	152	1197.28	amplification	PASNZU_01_TARGET
TARGET-30-PASPER-01A-01D	TARGET-30-PASPER-01A-01R	PASPER	MYCN	Neuroblastoma	MYCN non-amp	2	16.46	neutral	PASPER_01_TARGET
TARGET-30-PASRFS-01A-01D	TARGET-30-PASRFS-01A-01R	PASRFS	MYCN	Neuroblastoma	MYCN non-amp	2	51.69	neutral	PASRFS_01_TARGET
TARGET-30-PASSRN-01A-01D	TARGET-30-PASSRN-01A-01R	PASSRN	MYCN	Neuroblastoma	MYCN amp	522	836.66	amplification	PASSRN_01_TARGET
TARGET-30-PASSRS-01A-01D	TARGET-30-PASSRS-01A-01R	PASSRS	MYCN	Neuroblastoma	MYCN non-amp	2	21.15	loss	PASSRS_01_TARGET
TARGET-30-PASTCN-01A-01D	TARGET-30-PASTCN-01A-01R	PASTCN	MYCN	Neuroblastoma	MYCN non-amp	2	41.76	loss	PASTCN_01_TARGET
TARGET-30-PASTKC-01A-01D	TARGET-30-PASTKC-01A-01R	PASTKC	MYCN	Neuroblastoma	MYCN non-amp	2	27.41	loss	PASTKC_01_TARGET
TARGET-30-PASUCB-01A-01D	TARGET-30-PASUCB-01A-01R	PASUCB	MYCN	Neuroblastoma	MYCN non-amp	2	12.61	loss	PASUCB_01_TARGET
TARGET-30-PASUYG-01A-01D	TARGET-30-PASUYG-01A-01R	PASUYG	MYCN	Neuroblastoma	MYCN non-amp	3	9.05	neutral	PASUYG_01_TARGET
TARGET-30-PASVRU-01A-01D	TARGET-30-PASVRU-01A-01R	PASVRU	MYCN	Neuroblastoma	MYCN amp	121	553.88	amplification	PASVRU_01_TARGET
TARGET-30-PASWFB-01A-01D	TARGET-30-PASWFB-01A-01R	PASWFB	MYCN	Neuroblastoma	MYCN amp	195	1168.07	amplification	PASWFB_01_TARGET
TARGET-30-PASWIJ-01A-01D	TARGET-30-PASWIJ-01A-01R	PASWIJ	MYCN	Neuroblastoma	MYCN non-amp	3	63.29	neutral	PASWIJ_01_TARGET
TARGET-30-PASWVY-01A-01D	TARGET-30-PASWVY-01A-01R	PASWVY	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	4	86.39	gain	PASWVY_01_TARGET
TARGET-30-PASWYR-01A-01D	TARGET-30-PASWYR-01A-01R	PASWYR	MYCN	Neuroblastoma	MYCN amp	138	1165.28	amplification	PASWYR_01_TARGET
TARGET-30-PASXGP-01A-01D	TARGET-30-PASXGP-01A-01R	PASXGP	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	61.36	neutral	PASXGP_01_TARGET
TARGET-30-PASXHE-01A-01D	TARGET-30-PASXHE-01A-01R	PASXHE	MYCN	Neuroblastoma	MYCN non-amp	3	82.16	gain	PASXHE_01_TARGET
TARGET-30-PASXIE-01A-01D	TARGET-30-PASXIE-01A-01R	PASXIE	MYCN	Neuroblastoma	MYCN amp	3	1399.01	gain	PASXIE_01_TARGET
TARGET-30-PASXRG-01A-01D	TARGET-30-PASXRG-01A-01R	PASXRG	MYCN	Ganglioneuroblastoma, nodular	MYCN amp	14	306.49	amplification	PASXRG_01_TARGET
TARGET-30-PASXRJ-01A-01D	TARGET-30-PASXRJ-01A-01R	PASXRJ	MYCN	Neuroblastoma	MYCN non-amp	2	40.16	neutral	PASXRJ_01_TARGET
TARGET-30-PASYPX-01A-01D	TARGET-30-PASYPX-01A-01R	PASYPX	MYCN	Neuroblastoma	MYCN non-amp	3	35.42	neutral	PASYPX_01_TARGET
TARGET-30-PASZPI-01A-01D	TARGET-30-PASZPI-01A-01R	PASZPI	MYCN	Neuroblastoma	MYCN amp	44	1114.27	amplification	PASZPI_01_TARGET
TARGET-30-PATBMM-01A-01D	TARGET-30-PATBMM-01A-01R	PATBMM	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	18.62	loss	PATBMM_01_TARGET
TARGET-30-PATCFL-01A-01D	TARGET-30-PATCFL-01A-01R	PATCFL	MYCN	Neuroblastoma	MYCN non-amp	2	7.7	neutral	PATCFL_01_TARGET
TARGET-30-PATDWN-01A-01D	TARGET-30-PATDWN-01A-01R	PATDWN	MYCN	Neuroblastoma	MYCN amp	238	1794.12	amplification	PATDWN_01_TARGET
TARGET-30-PATDXC-01A-01D	TARGET-30-PATDXC-01A-01R	PATDXC	MYCN	Neuroblastoma	MYCN non-amp	3	66.34	neutral	PATDXC_01_TARGET
TARGET-30-PATDXG-01A-01D	TARGET-30-PATDXG-01A-01R	PATDXG	MYCN	Neuroblastoma	MYCN amp	118	1668.97	amplification	PATDXG_01_TARGET
TARGET-30-PATEKG-01A-01D	TARGET-30-PATEKG-01A-01R	PATEKG	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	6.18	neutral	PATEKG_01_TARGET
TARGET-30-PATEPF-01A-01D	TARGET-30-PATEPF-01A-01R	PATEPF	MYCN	Ganglioneuroblastoma, nodular	MYCN non-amp	2	48.17	neutral	PATEPF_01_TARGET
TARGET-30-PATESI-01A-01D	TARGET-30-PATESI-01A-01R	PATESI	MYCN	Neuroblastoma	MYCN amp	105	1468	amplification	PATESI_01_TARGET
TARGET-30-PATFCY-01A-01D	TARGET-30-PATFCY-01A-01R	PATFCY	MYCN	Neuroblastoma	MYCN non-amp	2	73.78	loss	PATFCY_01_TARGET
TARGET-30-PATFXV-01A-01D	TARGET-30-PATFXV-01A-01R	PATFXV	MYCN	Neuroblastoma	MYCN amp	188	1768.19	amplification	PATFXV_01_TARGET
TARGET-30-PATGLU-01A-01D	TARGET-30-PATGLU-01A-01R	PATGLU	MYCN	Neuroblastoma	MYCN non-amp	3	56.8	gain	PATGLU_01_TARGET
TARGET-30-PATHVK-01A-01D	TARGET-30-PATHVK-01A-01R	PATHVK	MYCN	Neuroblastoma	MYCN non-amp	4	29.58	neutral	PATHVK_01_TARGET
TARGET-30-PATINJ-01A-01D	TARGET-30-PATINJ-01A-01R	PATINJ	MYCN	Neuroblastoma	MYCN non-amp	2	64.06	neutral	PATINJ_01_TARGET
BS_0XC02E11	BS_2HM4AE24	PT_V5PCYAFJ	NA	Neuroblastoma	NA	NA	NA	NA	PT_V5PCYAFJ_ET_FD9T78QE_DGD
BS_1F8J25Q1	BS_2HM4AE24	PT_V5PCYAFJ	NA	Neuroblastoma	NA	NA	NA	NA	PT_V5PCYAFJ_ET_FD9T78QE_DGD
BS_3ZHNXCAJ	BS_EY0C9N6Z	PT_CQN8M3RF	NA	Neuroblastoma	NA	NA	NA	NA	PT_CQN8M3RF_ET_44GZCX5A_DGD
BS_41GN9XGX	BS_327GE38E	PT_TMY5EVG3	NA	Neuroblastoma	Neuroblastoma of the Adrenal Gland and Sympathetic Nervous System	NA	NA	NA	PT_TMY5EVG3_ET_0QD356EC_DGD
BS_4MWP3Z92	BS_JKR644RJ	PT_RBCEW1B3	NA	Neuroblastoma	NA	NA	NA	NA	PT_RBCEW1B3_ET_5GJA7Q72_DGD
BS_60ZFFGXZ	BS_V8AE965P	PT_Y5YHX20Q	NA	Neuroblastoma	Neuroblastoma of the Adrenal Gland and Sympathetic Nervous System	NA	NA	NA	PT_Y5YHX20Q_ET_06Q9BSNT_DGD
BS_74G0GZ00	BS_JHEHJN1M	PT_0Q496N0Q	NA	Neuroblastoma	NA	NA	NA	NA	PT_0Q496N0Q_ET_DVMP5JR3_DGD
BS_756MTKTC	BS_PTTZ15MN	PT_203SE2J7	NA	Neuroblastoma	NA	NA	NA	NA	PT_203SE2J7_ET_2SFY7T52_DGD
BS_7CG7E8XJ	BS_RWZRY9CF	PT_D19XT3GV	NA	Neuroblastoma	Neuroblastoma of the Adrenal Gland and Sympathetic Nervous System	NA	NA	NA	PT_D19XT3GV_ET_6JGS3HVH_DGD
BS_8072ADGT	BS_T88CNJ8A	PT_JPFR0046	NA	Neuroblastoma	Recurrent Neuroblastoma	NA	NA	NA	PT_JPFR0046_ET_AX052MKD_DGD
BS_83HX4CXB	BS_B9XBBA8D	PT_5ZPPR06P	NA	Neuroblastoma	metastatic peripheral neuroblastic tumor	NA	NA	NA	PT_5ZPPR06P_ET_1QEB44PQ_DGD
BS_87NQHSBG	BS_YP080MN8	PT_23G70TEN	NA	Neuroblastoma	NA	NA	NA	NA	PT_23G70TEN_ET_6JDFDV10_DGD
BS_9QFGAB8A	BS_TSNBH5A6	PT_DF18YV38	NA	Neuroblastoma	Adrenal Gland Neuroblastoma	NA	NA	NA	PT_DF18YV38_ET_1CFP6054_DGD
BS_ADNFY748	BS_R91DDK9A	PT_HVCRDJ95	NA	Neuroblastoma	High Risk Neuroblastoma	NA	NA	NA	PT_HVCRDJ95_ET_AWW0E9A6_DGD
BS_B8F0WNZC	BS_7KTGJPVN	PT_Y44DNH44	NA	Neuroblastoma	NA	NA	NA	NA	PT_Y44DNH44_ET_E5CPBMPG_DGD
BS_CZVNMYM3	BS_9NME41F4	PT_JQA14J4Z	NA	Neuroblastoma	NA	NA	NA	NA	PT_JQA14J4Z_ET_39DZBCF4_DGD
BS_DNJ7T9PZ	BS_JS7G87QP	PT_JPBMNESN	NA	Neuroblastoma	Neuroblastoma of the Adrenal Gland and Sympathetic Nervous System	NA	NA	NA	PT_JPBMNESN_ET_C228BTEJ_DGD
BS_GK471D0T	BS_9Z1VTWJV	PT_K0YFKQ6V	NA	Neuroblastoma	peripheral neuroblastic tumor status post-chemotherapy	NA	NA	NA	PT_K0YFKQ6V_ET_A4K76DSF_DGD
BS_JQ2S9D9T	BS_WAH4KKQ5	PT_HGWCJDHV	NA	Neuroblastoma	NA	NA	NA	NA	PT_HGWCJDHV_ET_FFDK4P5W_DGD
BS_K58DN77T	BS_V1Q5A9B1	PT_5ZPPR06P	NA	Neuroblastoma	neuroblastoma	NA	NA	NA	PT_5ZPPR06P_7316-4214_DGD
BS_NQ41MEBX	BS_XBQDMMB3	PT_QHJSYTWJ	NA	Neuroblastoma	neuroblastoma (schwannian stroma poor),	NA	NA	NA	PT_QHJSYTWJ_7316-8120_DGD
BS_NRJA5JT9	BS_29E2B8BX	PT_GRZE094W	NA	Neuroblastoma	High Risk Neuroblastoma	NA	NA	NA	PT_GRZE094W_ET_AFWA6XC1_DGD
BS_RECF1S4Q	BS_H9YYADDT	PT_BCBMG74N	NA	Neuroblastoma	NA	NA	NA	NA	PT_BCBMG74N_ET_EJ3H8NNB_DGD
BS_TYZH6BSG	BS_9P9DNAHS	PT_J01MB51G	NA	Neuroblastoma	NA	NA	NA	NA	PT_J01MB51G_ET_DJ152PHW_DGD
BS_V5N71HQS	BS_8Y7V5264	PT_RBCEW1B3	NA	Neuroblastoma	NA	NA	NA	NA	PT_RBCEW1B3_ET_4Z0Y8YHR_DGD
BS_XGH76HBE	BS_8P02DSEP	PT_TC6A6TX7	NA	Neuroblastoma	NA	NA	NA	NA	PT_TC6A6TX7_ET_4SC6AA4T_DGD
BS_XMADRSG8	BS_ZZA88AMB	PT_8KF6YSTW	NA	Neuroblastoma	NA	NA	NA	NA	PT_8KF6YSTW_ET_5K8PDRFC_DGD
BS_YBXM34XV	BS_A05MJ45Y	PT_K0YFKQ6V	NA	Neuroblastoma	peripheral neuroblastic tumor status post-chemotherapy	NA	NA	NA	PT_K0YFKQ6V_7316-7085_DGD
